Supplying drugs that cannot be sold legally in many parts of the world sounds like the sort of activity that might interest the police.
However, Clinigen, which has a vast warehouse just off the M25, is hoping it can attract investors instead.
The AIM-listed medicines distributer specialises in transporting tablets and vaccines to patients who cannot get access to the drugs through normal channels. Acting as a middleman, it can send a medicine that has been approved for use somewhere in the world to somewhere it has yet to get the green light — and add a mark-up for its trouble.
Demand for its services is set to surge in the next decade as patients, often in emerging markets, become more aware of the availability